144 related articles for article (PubMed ID: 34511584)
1. Better method for detection of CD30: Immunohistochemistry or flow cytometry?
Higashi M; Kikuchi J; Murakami C; Takayanagi N; Momose S; Kizaki M; Tamaru JI
J Clin Exp Hematop; 2021 Dec; 61(4):221-223. PubMed ID: 34511584
[TBL] [Abstract][Full Text] [Related]
2. Utility of a new notation to visualize flow cytometry analysis results: first preliminary comparison with immunohistochemistry to detect CD30 expression on T-cell lymphoma cells.
Fujishima F; Fukuhara N; Katsushima H; Nakamura Y; Harigae H; Sasano H; Ichinohasama R
BMC Cancer; 2021 Dec; 21(1):1352. PubMed ID: 34930176
[TBL] [Abstract][Full Text] [Related]
3. Multicentric MFI30 study: Standardization of flow cytometry analysis of CD30 expression in non-Hodgkin lymphoma.
Debliquis A; Baseggio L; Bouyer S; Guy J; Garnache-Ottou F; Genevieve F; Mayeur-Rousse C; Letestu R; Chapuis N; Harrivel V; Bennani H; Lachot S; Loosveld M; Nicolino-Brunet C; Pérès M; Roussel M; Veyrat-Masson R; Jacob MC; Drenou B
Cytometry B Clin Cytom; 2021 Jul; 100(4):488-496. PubMed ID: 32803917
[TBL] [Abstract][Full Text] [Related]
4. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
[TBL] [Abstract][Full Text] [Related]
5. Rare occurrence of CD30+ circulating cells in patients with cutaneous CD30+ anaplastic large cell lymphoma: a study of nine patients.
Dereure O; Portales P; Balavoine M; Corbeau P; Guillot B; Clot J; Guilhou JJ
Br J Dermatol; 2003 Feb; 148(2):246-51. PubMed ID: 12588375
[TBL] [Abstract][Full Text] [Related]
6. CD30 Expression in Oral and Oropharyngeal Diffuse Large B Cell Lymphoma, not Otherwise Specified.
Morais-Perdigão AL; Rodrigues-Fernandes CI; Araújo GR; Soares CD; de Andrade BAB; Martins MD; Vargas PA; Pontes HAR; Pires FR; Burbano RMR; Fonseca FP
Head Neck Pathol; 2022 Jun; 16(2):476-485. PubMed ID: 34655411
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features and prognostic significance of CD30 expression in
Salas MQ; Climent F; Tapia G; DomingoDomènech E; Mercadal S; Oliveira AC; Aguilera C; Olga G; Moreno Velázquez M; Andrade-Campos M; Encuentra M; Fernández de Sevilla A; Sureda A; Sancho JM; González-Barca E
Biomarkers; 2020 Feb; 25(1):69-75. PubMed ID: 31752540
[No Abstract] [Full Text] [Related]
8. CD30 expression and prognostic significance in R-EPOCH-treated patients with diffuse large B-cell lymphoma.
Xu J; Oki Y; Saksena A; Desai P; Lin P; Tang G; Yin CC; You MJ; Thakral B; Medeiros LJ; Li S
Hum Pathol; 2017 Feb; 60():160-166. PubMed ID: 27816715
[TBL] [Abstract][Full Text] [Related]
9. Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry.
Bartlett NL; Smith MR; Siddiqi T; Advani RH; O'Connor OA; Sharman JP; Feldman T; Savage KJ; Shustov AR; Diefenbach CS; Oki Y; Palanca-Wessels MC; Uttarwar M; Li M; Yang J; Jacobsen ED
Leuk Lymphoma; 2017 Jul; 58(7):1607-1616. PubMed ID: 27868471
[TBL] [Abstract][Full Text] [Related]
10. BCL-6 protein expression in human peripheral T-cell neoplasms is restricted to CD30+ anaplastic large-cell lymphomas.
Carbone A; Gloghini A; Gaidano G; Dalla-Favera R; Falini B
Blood; 1997 Sep; 90(6):2445-50. PubMed ID: 9310496
[TBL] [Abstract][Full Text] [Related]
11. Factors determining whether diffuse large B-cell lymphoma samples are detected by flow cytometry.
Peng D; Kodituwakku A; Le S; Smith SABC; Qiu MR; Earls P; Field AS; Parker AJC; Law M; Milliken ST; Sewell WA
Int J Lab Hematol; 2023 Dec; 45(6):927-934. PubMed ID: 37632200
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic Large Cell Lymphoma.
Medeiros LJ; Elenitoba-Johnson KS
Am J Clin Pathol; 2007 May; 127(5):707-22. PubMed ID: 17511113
[TBL] [Abstract][Full Text] [Related]
13. De novo diffuse large B-cell lymphoma with a CD20 immunohistochemistry-positive and flow cytometry-negative phenotype: molecular mechanisms and correlation with rituximab sensitivity.
Tokunaga T; Tomita A; Sugimoto K; Shimada K; Iriyama C; Hirose T; Shirahata-Adachi M; Suzuki Y; Mizuno H; Kiyoi H; Asano N; Nakamura S; Kinoshita T; Naoe T
Cancer Sci; 2014 Jan; 105(1):35-43. PubMed ID: 24147568
[TBL] [Abstract][Full Text] [Related]
14. CD30 expression and survival in posttransplant lymphoproliferative disorders.
Kinch A; Amini RM; Hollander P; Molin D; Sundström C; Enblad G
Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
[No Abstract] [Full Text] [Related]
15. CD30-Positive Anaplastic Variant of Diffuse Large B-cell Lymphoma: Frequency and Association With Clinicopathological Parameters.
Hashmi AA; Haider R; Nargus G; Ahmed O; Yaqeen SR; Asghar IA; Afzal A; Irfan M; Edhi MM; Ali J
Cureus; 2021 Feb; 13(2):e13209. PubMed ID: 33717748
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of mature T-cell and NK-cell lymphoma with CD30 expression based on latest WHO classification].
Feng Y; Fu J; Yan S; Ling Y; Huang Y; Cai M; Rao H
Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):508-11. PubMed ID: 25346118
[TBL] [Abstract][Full Text] [Related]
17. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma.
Kinney MC; Collins RD; Greer JP; Whitlock JA; Sioutos N; Kadin ME
Am J Surg Pathol; 1993 Sep; 17(9):859-68. PubMed ID: 8394652
[TBL] [Abstract][Full Text] [Related]
18. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME
Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ
Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692
[TBL] [Abstract][Full Text] [Related]
20. CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma.
Gong QX; Wang Z; Liu C; Li X; Lu TX; Liang JH; Xu W; Li JY; Zhang ZH
J Clin Pathol; 2018 Sep; 71(9):795-801. PubMed ID: 29666157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
